Yale University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Yale University sits in the top decile of US sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count).
Yale University: 1,492 sponsored US clinical trials, 254 recruiting.
Yale University sponsors 1,492 registered US clinical trials on ClinicalTrials.gov, 254 of them currently recruiting, and 1,005 completed. 99 of these trials are in Phase 3-4 (later-stage) and 579 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 19 trials.
Top-decile sponsor footprint
Yale University ranks in the top decile of sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,005 of 1,138 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,492 total, page 12 of 30
Comparing a Fatherhood Focused Individual Intervention to Batterer Intervention to Reduce IPV and Child Maltreatment
NCT04165291
CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes
NCT04219085
Drug-Targeted Alerts for Acute Kidney Injury
NCT02771977
Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease
NCT04745624
Coordinating Opioid Use Treatment Through Medical Management With Infection Treatment (Project COMMIT)
NCT04180020
Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)
NCT04402385
Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.
NCT04386811
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
NCT04490057
Postoperative Dexamethasone on Post-Cesarean Pain
NCT04067609
Virtual cOaching in Making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
NCT03834870
A Novel Tapered Applicator for Vaginal Vault Brachytherapy
NCT04318340
Emergency Department-Initiated Buprenorphine Validation Network Trial
NCT04225598
Intermittent Versus Continuous Enteral Nutrition in Mechanically Ventilated Patients in the Medical Intensive Care Unit
NCT04437264
COVID-19 Vaccine Messaging, Part 1
NCT04460703
SafetyNet Program for Opioid Use Disorder (OUD)
NCT04253782
Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality
NCT04380116
Very Low Carbohydrate Diet as an Adjunctive Therapy for Youth Type 1 Diabetes
NCT04082884
Treatment of Pregnant Women With OUD
NCT04240392
TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer
NCT04166435
Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects
NCT04431908
Camostat Mesylate in COVID-19 Outpatients
NCT04353284
Study of an App to Facilitate Communication With Parents of Febrile Infants
NCT04328909
The Role of Resistant Starch in COVID-19 Infection
NCT04342689
A Trial of Online LGBTQ-affirmative Cognitive Behavioral Therapy to Reduce Depression and Associated Health Risks Among Young Adults
NCT04408469
Patient-centered Approaches to Provider and Adolescent Reproductive Health Communication and Shared Decision-making
NCT03670745
QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events
NCT04514523
Acute Effects of Vaping Nicotine on Cognition in Young Adults
NCT04901208
BXCL501 for Agitation in Schizophrenia
NCT03708315
Imaging Glutamate Release From Alcohol
NCT04159688
Models of Auditory Hallucination
NCT04210557
Resuscitative EndoVascular Aortic Occlusion for Maximal Perfusion
NCT03703453
A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL)
NCT04171791
Voiding Diary Video
NCT04233645
Mobile Physical Activity for Type 1 Diabetes
NCT04204733
Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients
NCT03666065
Risk EValuation And Its Impact on ClinicAL Decision Making and Outcomes in Heart Failure
NCT03845660
Relief of Symptoms of Post-traumatic Stress for Victims of Gun Violence
NCT03916614
Promoting Medications for Alcohol Use Disorder on the General Medicine Service
NCT04287790
Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating
NCT04088097
Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)
NCT03469505
Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer
NCT04111510
Social Value Training in Toddlers With Elevated Autism Symptoms
NCT03556826
GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia
NCT04051996
Pathogenesis of the Cardiometabolic Risk in Youth With Type 1 Diabetes
NCT04101045
Pilot: Feasibility of Intermittent Enteral Feeding in Ventilated MICU Patients
NCT04164108
Smoking by IV Pulsed Nicotine
NCT04488744
Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD
NCT03658642
Examining the Effect of Burosumab on Muscle Function
NCT04146935
Computer Presented and Physical Exercises to Maintain Cognitive Function and Emotional Health in Older Adults
NCT04404621
Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes
NCT02693938
What is open in the Yale University pipeline
254 recruiting of 1,492 indexed (17% open); 1,005 completed (67%).
Phase mix: 99 late (III/IV) vs 579 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Yale University: open-pipeline peers nationwide
Peers matched on 1,492 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Yale University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,492 trials (± recruiting share)
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- NYU Langone Health · 17% recruiting · 1,164 trials
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
Related
What to do with this Yale University page
1,492 registered trials is a research-attention snapshot, not an endorsement of Yale University or any single study.
- 254 of Yale University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Yale University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Yale University pipeline card: 1,492 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.